Page last updated: 2024-09-05

2-(nitrooxy)ethyl apovincaminate and Breast Cancer

2-(nitrooxy)ethyl apovincaminate has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Babilonia, MB; Bower, J; Cole, S; Culakova, E; Desta, Z; Han, HS; Heckler, C; Hoogland, AI; Janelsins, M; Jim, HSL; Morrow, G; Peppone, L; Williams, GC1

Trials

1 trial(s) available for 2-(nitrooxy)ethyl apovincaminate and Breast Cancer

ArticleYear
A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures.
    Contemporary clinical trials, 2020, Volume: 91

    Topics: Age Factors; Antidepressive Agents, Second-Generation; Breast Neoplasms; Bupropion; Cancer Survivors; Cytochrome P-450 CYP2B6; Delayed-Action Preparations; Depression; Double-Blind Method; Fatigue; Female; Health Behavior; Humans; Menopause; Quality of Life; Research Design; Socioeconomic Factors; Vinca Alkaloids

2020